Clinical guidelines for the management of depression with specific comorbid psychiatric conditions French recommendations from experts (the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental)

Affiliation auteurs!!!! Error affiliation !!!!
TitreClinical guidelines for the management of depression with specific comorbid psychiatric conditions French recommendations from experts (the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental)
Type de publicationJournal Article
Year of Publication2019
AuteursBennabi D., Yrondi A., Charpeaud T., Genty J.-B, Destouches S., Lancrenon S., Allaili N., Bellivier F., Bougerol T., Camus V., Doumy O., Dorey J.-M, Haesebaert F., Holtzmann J., Lancon C., Lefebvre M., Moliere F., Nieto I., Rabu C., Richieri R., Schmitt L., Stephan F., Vaiva G., Walter M., Leboyer M., El-Hage W., Aouizerate B., Haffen E., Llorca P.-M, Courtet P.
JournalBMC PSYCHIATRY
Volume19
Pagination50
Date PublishedJAN 30
Type of ArticleArticle
ISSN1471-244X
Mots-clésAnxiety disorders, Elderly, Major depressive disorder, Pharmacotherapy, Substance use disorders
Résumé

BackgroundRecommendations for pharmacological treatments of major depression with specific comorbid psychiatric conditions are lacking.MethodThe French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental developed expert consensus guidelines for the management of depression based on the RAND/UCLA Appropriatneness Method. Recommendations for lines of treatment are provided by the scientific committee after data analysis and interpretation of the results of a survey of 36 psychiatrist experts in the field of major depression and its treatments.ResultsThe expert guidelines combine scientific evidence and expert clinician's opinion to produce recommendations for major depression with comorbid anxiety disorders, personality disorders or substance use disorders and in geriatric depression.ConclusionThese guidelines provide direction addressing common clinical dilemmas that arise in the pharmacologic treatment of major depression with comorbid psychiatric conditions.

DOI10.1186/s12888-019-2025-7